Medtech Imricor ‘laying the foundations’ for growth after momentum builds in Q1 CY24
Imricor reactivates hospital customer sites in Q1 CY24 with momentum building Company progresses pivotal VISABL-AFL trial during quarter required for US FDA approval IMR receives Medical Device Marketing Authorisation from the Saudi Food & Drug …